Clinical Trials Browser

Prostatic Neoplasms × Pafolacianine × 90 days × Clear all

NCT06434909 2026-06-01

CYTALUX™for the Intraoperative Imaging of Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms